Lodotra – a unique modified-release formulation designed to be taken before bed and release low-dose prednisone in the early hours when inflammatory cytokines peak – achieves clinically significant improvements in ACR20, morning stiffness and pain in patients with rheumatoid arthritis (RA), according to results from clinical trials presented at the 11th Annual European League Against Rheumatism (EULAR) congress.

Read the full story here